Innovation for Health - 15-16 April 2021
Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Rob de Ree

Operating Partner, Biogeneration Ventures

Rob is operating partner at BGV since 2016, serving on the board and in interim management positions in the fund’s portfolio companies. Currently he is CEO of NorthSea Therapeutics and serves on the board of Mellon Medical. Previously he was the Chairman of SurgVision.
Rob started his career in pharma in 1991 in sales and marketing at the cardiovascular division of Byk Gulden. Rob joined Medtronic in 1996 where he worked in various sales and marketing roles.Rob moved to Crucell where he led the licensing business after which he joined BMEYE, a startup in hemodynamic monitoring where he serves as CEO until it was sold to Edwards Lifesciences. Rob was subsequently CEO of Dezima Pharma , which was sold to Amgen in October 2015.
Rob holds a MSc in pharmacy from the University of Groningen.
Jan van de Winkel
Genmab
Eline Vrijland-van Beest
Hybridize Therapeutics

Carmen van Vilsteren
Topsector Life Science & Health

Tim Van Hauwermeiren 
argenx

Antoon van Oosterhout
Imyse SA
Willem Mulder
TU/E
Jolanda M. de Vries
Radboudumc
Yvette van Kooyk
Amsterdam UMC
Ronald Plasterk
Frame Cancer Therapeutics
Paul WG Elbers
Amsterdam UMC
Prof. Dr. Ing. Ron A.M. Fouchier
Erasmus MC
Sponsors & Partners 2021
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Main Virtual Conference sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: www.innovationforhealth.nl/privacy-policy